Skip to main content

News categories: Publication

20 years RIG-I

An intriguing review reflecting on the development in the RIG-I research published in 'Immunity'.

Prof. Takashi Fujita from the Institute of Virus Research at the university of Bonn, Prof. Mitsutoshi Yoneyama from the Research Institute of Disaster Medicine at the Chiba University and Prof. Hiroki Kato from the Institute of Cardiovascular Immunology at the University Hospital in Bonn now published a collaborative review article in celebration of 20 years after the discovery of RIG-I. The article delves into the captivating realm of RIG-I research, exploring the advancements made over the past two decades. Published in the latest edition of "Immunity," the review sheds light on the critical role of Retinoic Acid-Inducible Gene I (RIG-I) receptors in the innate immune system.

Recognized as pattern recognition receptors (PRRs), RIG-I receptors play a crucial role in detecting viral RNA and initiating antiviral responses. Their discovery in the early 2000s revolutionized virology research, positioning RIG-I receptors as vital targets for therapeutic intervention against viral infections. Moreover, their involvement in autoimmune diseases, cancer immunotherapy, and vaccine development underscores their broad significance in biomedical research.

Summary


The RIG-I like receptor (RLR) is crucial for pathogen detection and triggering immune responses, and have immense physiological importance. In this review, we first summarize the interferon system and innate immunity, which constitute primary and secondary responses. Next, the molecular structure of RLR and the mechanism of sensing non-self RNA are described. Usually, self-RNA is refractory to RLR; however, there are underlying host mechanisms that prevent immune reactions. Studies have revealed that the regulatory mechanisms of RLR involve covalent molecular modifications, association with regulatory factors, and subcellular localization. Viruses have evolved to acquire antagonistic RLR functions to escape the host immune reactions. Finally, the pathologies caused by the malfunction of RLR signaling are described.

Mitsutoshi Yoneyama, Takashi Fujita and Hiroki Kato
Takashi Fujita (middle), Mitsutoshi Yoneyama (left) and Hiroki Kato (right). Picture taken in 2014.

Publication:

Mitsutoshi Yoneyama, Hiroki Kato, Takashi Fujita (2024), Volume 57, Issue 4, Pages 731-751

Physiological functions of RIG-I-like receptors

DOI: https://doi.org/10.1016/j.immuni.2024.03.003

Contact:

Prof. Hiroki Kato
Institute of Cardiovascular Immunology
University Hospital Bonn
E-mail: hkato@uni-bonn.de

Related news

20240523 PM  Hoelzel Herrlinger Layer 1212 wp header

News categories: Publication

Novel RNA therapy is effective against highly aggressive brain tumors

The findings of the GLORIA study were published in "Nature Communications"
View entry
20240506 PM Hoerauf Achim 2048x854px

News categories: Publication

New antibiotic against river blindness and lymphatic filariasis pathogens

Japanese fund supports research into the treatment of filarial infections at University Hospital Bonn.
View entry
20240321 PM PM Klumper 010

News categories: Publication

Bonn scientists predict the connection between biomarker expression and long-term survival in patients with urothelial cancer

PD Dr. Niklas Klümper and Prof. Michael Hölzel discovered that NECTIN4 amplifications are genomic predictors of long-term survival in patients suffering from metastatic urothelial cancer (mUC). Their findings were published in the latest edition of the “Journal of Clinical Oncology”.
View entry

Back to the news overview